Docetaxel immunonanocarriers as targeted delivery systems for HER2-positive tumor cells: preparation, characterization, and cytotoxicity studies
Mona Noori Koopaei1, Rassoul Dinarvand1,2, Mohsen Amini3, Hojatollah Rabbani4, Shaghayegh Emami4, Seyed Nasser Ostad5, Fatemeh Atyabi1,21Novel Drug Delivery Laboratory, Faculty of Pharmacy, 2Nanotechnology Research Center, 3Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of...
Guardado en:
Autores principales: | Noori Koopaei M, Dinarv, R, Amini M, Rabbani H, Emami S, Ostad SN, Atyabi F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de02f899e15d4fc59bf55fc3b443a105 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Ostad SN, et al.
Publicado: (2012) -
Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour P, et al.
Publicado: (2011) -
Targeted delivery of doxorubicin to HER2 positive tumor models
por: Gomari H, et al.
Publicado: (2019) -
Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
por: Gomari H, et al.
Publicado: (2019) -
Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation
por: Shahrooz Saremi, et al.
Publicado: (2011)